SIC
AGN

SFE Investment Counsel’s Allergan plc AGN Stock Holding History

SFE Investment Counsel’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,030
Closed -$338K – 128
2018
Q2 		$338K Sell
2,030
-90
-4% -$14.4K 0.14% 109
2018
Q1 		$357K Buy
2,120
+655
+45% +$110K 0.19% 88
2017
Q4 		$240K Buy
+1,465
New +$263K 0.1% 105

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SFE Investment Counsel's AGN Position: Q3 2018 in Review

SFE Investment Counsel sold out of Allergan plc (AGN) in Q3 2018, closing a stake of 2,030 shares — an estimated $338K sold.

SFE Investment Counsel first reported a position in AGN in Q4 2017 and held it in 3 quarters. The position peaked at $357K in Q1 2018. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.

  • SFE Investment Counsel reported no remaining Allergan plc position as of Q3 2018 after selling out during the quarter.
  • SFE Investment Counsel sold 2,030 Allergan plc shares in Q3 2018, an estimated $338K.
  • SFE Investment Counsel first reported a position in Allergan plc in Q4 2017 and held it in 3 quarters.
  • SFE Investment Counsel's Allergan plc position peaked at $357K in Q1 2018.
  • 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.

Based on SFE Investment Counsel's 13F filing for Q3 2018, filed 31 Oct 2018.